pipette
ENEnglish

The p38α MAPK–MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression

Xiaoxia Xing, Zhihao Zhang, Longxia Li, Zhouying Shen, Buri Xi, Yixuan Yang, Min Diao, Li Ye, Junxiu Chen, Guanglei Zhuang, Xiaoming Zhou, Ahmed A. Ahmed, Hai Gong, Rongyu Zang, Yiyan Zheng

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Nuclear F-actin facilitates DNA damage repair and contributes to cancer chemoresistance. However, the regulatory mechanisms controlling its dynamic polymerization in response to genotoxic stress remain poorly defined. A major barrier in nuclear actin research is the lack of tools for precise, high-throughput analysis. To systematically investigate nuclear F-actin assembly in DNA damage response, we developed a deep learning pipeline, named nFANet, for high-throughput detection and analysis of nuclear F-actin. Here, using ovarian cancer—a malignancy where chemoresistance is a major clinical obstacle—as a model, we showed that platinum-based chemotherapy robustly induces nuclear F-actin assembly. A subsequent kinome screening, in combination with the application of nFANet, identified the kinase p38α MAPK as a critical upstream regulator of platinum-induced nuclear F-actin assembly. Mechanistically, the p38α MAPK–MK2 signaling pathway promotes formin-mediated nuclear F-actin assembly in response to chemotherapy. Importantly, pharmacological inhibition or genetic knockout of the p38α MAPK–MK2 pathway sensitized ovarian cancer cells to platinum-based therapy. Our work uncovers a key mechanism governing nuclear actin remodeling under genotoxic stress and lays the foundation for identifying a patient subgroup likely to benefit from therapeutic targeting of this pathway.

Resultado principalEl resumen no menciona limitaciones.

Apareció: sábado, 14 de noviembre. Proceedings of the National Academy of Sciences. Revista con revisión por pares.

DOI: 10.1073/pnas.2615905123